Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

William Steinbach to Clinical Trials as Topic

This is a "connection" page, showing publications William Steinbach has written about Clinical Trials as Topic.

 
Connection Strength
 
 
 
0.342
 
  1. Steinbach WJ, Lamoth F, Juvvadi PR. Potential Microbiological Effects of Higher Dosing of Echinocandins. Clin Infect Dis. 2015 Dec 01; 61 Suppl 6:S669-77.
    View in: PubMed
    Score: 0.110
  2. Steinbach WJ, Benjamin DK. New antifungal agents under development in children and neonates. Curr Opin Infect Dis. 2005 Dec; 18(6):484-9.
    View in: PubMed
    Score: 0.055
  3. Steinbach WJ. Antifungal agents in children. Pediatr Clin North Am. 2005 Jun; 52(3):895-915, viii.
    View in: PubMed
    Score: 0.053
  4. Steinbach WJ. New findings and unique aspects in pediatric aspergillosis. Med Mycol. 2005 May; 43 Suppl 1:S261-5.
    View in: PubMed
    Score: 0.053
  5. Zaas AK, Steinbach WJ. Micafungin: the US perspective. Expert Rev Anti Infect Ther. 2005 Apr; 3(2):183-90.
    View in: PubMed
    Score: 0.053
  6. Zaoutis T, Lehrnbecher T, Groll AH, Steinbach WJ, Jafri HS, Maertens J, Ngai AL, Chow JW, Taylor AF, Strohmaier KM, Bourque M, Bradshaw SK, Petrecz M, Kartsonis NA. Safety experience with caspofungin in pediatric patients. Pediatr Infect Dis J. 2009 Dec; 28(12):1132-5.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.